SMTL ID : 4joa.1

Crystal Structure of Human Anaplastic Lymphoma Kinase in complex with 7-azaindole based inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.70 Å

Oligo State

monomer

Ligands

1 x 3DK: 3-[1-(2,5-difluorobenzyl)-1H-pyrazol-4-yl]-5-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[2,3-b]pyridine(Non-covalent)

3DK.1: 14 residues within 4Å: Chain A: A.82, K.84, F.98, E.101, I.105, I.128, L.130, E.131, M.133, G.136, L.190, G.203, D.204, R.209 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:E.101, A:I.105, A:I.128, A:L.130, A:L.190 Hydrogen bonds: A:E.131, A:M.133

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gummadi, V.R. et al., Discovery of 7-azaindole based anaplastic lymphoma kinase (ALK) inhibitors: wild type and mutant (L1196M) active compounds with unique binding mode. Bioorg.Med.Chem.Lett. (2013)

Release Date

2013-07-17

Peptides

ALK tyrosine kinase receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

ALK tyrosine kinase receptor

Related Entries With Identical Sequence